| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01764750 Details | 2018-05-11 Interventional | 1 | 10 | Vancomycin Infections Surgical Wound … Surgical Site I… | awaiting FDA approval for next dose group - | |||
| NCT00889187 Details | 2018-05-11 Interventional | 1/2 | [1 Refs] | 10 | Capecitabine Pancreatic Neop… Pancreatic Canc… | Excess toxicity was identified intraoperatively The study did not proceed to phase II due to unexpected intraoperative complications experienced by patients enrolled on phase I. | ||
| NCT00118196 Details | 2018-05-11 Interventional | 2 | 1 | Arsenic Trioxid… Azacitidine Leukemia Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome | Due to limited resources available to conduct study - | |||
| NCT03005639 Details | 2018-05-09 Interventional | 2 | 0 | Vemurafenib Melanoma Stage IIIB-C Me… | Sponsor has decided to close study. - | |||
| NCT02533323 Details | 2018-05-09 Interventional | 2 | 50 | Gemcitabine Oxaliplatin Pegaspargase Lymphoma Lymphoma, Extra… | - - | |||
| NCT02520479 Details | 2018-05-09 Interventional | 2 | 12 | Asparaginase Pegaspargase Treatment Refus… | - - | |||
| NCT02359162 Details | 2018-05-09 Interventional | 3 | [3 Refs] | 50 | Cyclophosphamid… Doxorubicin Etoposide Gemcitabine Oxaliplatin Pegaspargase Prednisone Vincristine Lymphoma Lymphoma, Extra… Lymphoma, T-Cel… Lymphoma, T-Cel… | The study is out of date - | ||
| NCT01354652 Details | 2018-05-09 Interventional | 4 | 5 | Entecavir Lamivudine Acidosis Acidosis, Lacti… Lactic Acidosis | Tenofovir has become available in Korea. - | |||
| NCT01172197 2008-002136-15 2008-002136-15 Details | 2018-05-09 Interventional | 4 | 14 | Levobupivacaine Ropivacaine Arthroplasty, R… Pain | Terminated prior to its planned completion as anticipated by the protocol). - | |||
| NCT02019589 Details | 2018-05-08 Interventional | 3 | 6 | Progesterone Amenorrhea Neoplasm Metast… Secondary Ameno… | - - | |||
| NCT01776008 Details | 2018-05-08 Interventional | 2 | 16 | Anastrozole Goserelin Breast Neoplasm… Estrogen Recept… HER2/Neu Negati… Recurrent Breas… Stage IIA Breas… Stage IIB Breas… Stage IIIA Brea… Stage IIIB Brea… Stage IIIC Brea… | Study did not pass Stage 1 interim analysis. - | |||
| NCT00695604 Details | 2018-05-08 Interventional | 2 | 0 | Fluticasone Asthma | Study was not able to be completed, no results analyzed. - | |||
| NCT01875185 Details | 2018-05-07 Interventional | 4 | 100 | Aspirin Acute Coronary … Inflammation Thrombosis | Lack of funds for specimen management and data analysis - | |||
| NCT03282188 Details | 2018-05-04 Interventional | 1/2 | 0 | Sargramostim Melanoma Skin Neoplasms Cancer of Skin | Withdrawn by Sponsor - | |||
| NCT02723435 Details | 2018-05-04 Interventional | 2 | 0 | Midostaurin Staurosporine Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… Adult Acute Mye… | Logistical and administrative issues - | |||
| NCT02332889 Details | 2018-05-04 Interventional | 1/2 | 1 | Decitabine Poly ICLC Glioma Medulloblastoma Neuroectodermal… Neuroectodermal… Gliomas | Transition to a different immunotherapy strategy in the future at our institution - | |||
| NCT02883426 Details | 2018-05-03 Interventional | 1 | 1 | Vaccines Influenza, Huma… Influenza | - - | |||
| NCT01680107 2012-003191-39 Details | 2018-05-03 Interventional | 3 | 33 | Cycloserine Panic Disorder | - - | |||
| NCT00738088 2007-000594-29 Details | 2018-05-03 Interventional | 4 | 14 | Gliclazide Diabetes Mellit… Diabetes Mellit… | Following Regulator inspection in 2009, study terminated as inadequate approvals were in place - | |||
| NCT02860897 Details | 2018-05-02 Interventional | 4 | 0 | Estrogens, Conj… Pelvic Floor Di… Estrogen Menopause Surgery | Unable to provide study medications due to cost. - |